2,3-Dichloro-6-methylquinoxaline - CAS 39267-05-5
Catalog: |
BB023923 |
Product Name: |
2,3-Dichloro-6-methylquinoxaline |
CAS: |
39267-05-5 |
Synonyms: |
2,3-dichloro-6-methylquinoxaline |
IUPAC Name: | 2,3-dichloro-6-methylquinoxaline |
Description: | 2,3-Dichloro-6-methylquinoxaline (CAS# 39267-05-5) is a useful research chemical. |
Molecular Weight: | 213.06 |
Molecular Formula: | C9H6Cl2N2 |
Canonical SMILES: | CC1=CC2=C(C=C1)N=C(C(=N2)Cl)Cl |
InChI: | InChI=1S/C9H6Cl2N2/c1-5-2-3-6-7(4-5)13-9(11)8(10)12-6/h2-4H,1H3 |
InChI Key: | UWSAFTDEEVGSAC-UHFFFAOYSA-N |
Boiling Point: | 289.1 °C at 760 mmHg |
Density: | 1.418 g/cm3 |
MDL: | MFCD00270819 |
LogP: | 3.24500 |
GHS Hazard Statement: | H302 (97.44%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P280, P301+P312, P305+P351+P338, P310, P330, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
KR-102070265-B1 | Novel [1,2,4]Triazolo[4,3-a]quinoxaline derivatives, preparation method therof, and pharmaceutical composition for use in preventing or treating BET protein related diseases containing the same as an active ingredient | 20170126 |
KR-20180089298-A | Novel [1,2,4]Triazolo[4,3-a]quinoxaline derivatives, preparation method therof, and pharmaceutical composition for use in preventing or treating BET protein related diseases containing the same as an active ingredient | 20170126 |
US-2020039984-A1 | Novel [1,2,4]Triazolo[4,3-a]Quinoxaline Derivative, Method For Preparing Same, And Pharmaceutical Composition For Preventing Or Treating BET Protein-Related Diseases, Containing Same As Active Ingredient | 20170126 |
WO-2018139876-A1 | Novel [1,2,4]triazolo[4, 3-a]quinoxaline derivative, method for preparing same, and pharmaceutical composition for preventing or treating bet protein-related diseases, containing same as active ingredient | 20170126 |
US-11028090-B2 | [1,2,4]Triazolo[4,3-a]quinoxaline derivative, method for preparing same, and pharmaceutical composition for preventing or treating BET protein-related diseases, containing same as active ingredient | 20170126 |
Complexity: | 189 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 211.9908036 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 211.9908036 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 25.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.5 |
-
Catalog: BB006288
1-Methyl-1,2,3,4-tetrahydroquinoxaline Dihydrochloride
Detail
-
Catalog: BB020903
2,3-Bis(bromomethyl)quinoxaline
Detail
-
Catalog: BB009208
1-(3-Chlorobenzyl)-1,2,3,4-tetrahydroquinoxaline Dihydrochloride
Detail
-
Catalog: BB017419
2,3-Dichloroquinoxaline
Detail
-
Catalog: BB016444
1-Methyl-1,4-dihydro-2,3-quinoxalinedione
Detail
-
Catalog: BB013542
2,3-Dichloro-6,7-dimethoxyquinoxaline
Detail
-
Catalog: BB019097
2,3,6,7-Tetrachloroquinoxaline
Detail
-
Catalog: BB026954
2-(4-Bromophenyl)quinoxaline
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoxalines
Customers Also Viewed
-
[84030-20-6]
1,3,4,6,7,8-Hexahydro-1-methyl-2H-pyrimido[1,2-a]pyrimidine
-
[6315-52-2]
Ethylene di(p-toluenesulfonate)
-
[7310-97-6]
2,5-Dimethoxybenzene-1,4-dicarboxaldehyde
-
[6342-17-2]
1,4-Bis(acryloyl)piperazine
-
[711-38-6]
2,2,2-Trifluoro-4'-methoxyacetophenone
-
[830-96-6]
3-Indolepropionic acid
INDUSTRY LEADERS TRUST OUR PRODUCTS